Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
B Acute Lymphoblastic Leukemia
Drug:
vincristine
(
Tubulin polymerization inhibitor
) +
dexamethasone
(
GCR agonist
)
Drug Class:
Tyrosine kinase inhibitor
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
04/04/2022
Excerpt:
Acute Lymphoblastic Leukemia...Regimens for Ph-positive B-ALL...TKI + vincristine + dexamethasone
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login